A randomized phase II trial of the antiangiogenic agent SU5416 in hormone-refractory prostate cancer

Walter M. Stadler, Dingcai Cao, Nicholas J. Vogelzang, Christopher W. Ryan, Kristin Hoving, Russell Wright, Theodore Karrison, Everett E. Vokes

Research output: Contribution to journalArticlepeer-review

84 Scopus citations

Fingerprint

Dive into the research topics of 'A randomized phase II trial of the antiangiogenic agent SU5416 in hormone-refractory prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences